Results 101 to 110 of about 7,625,232 (365)

The human gut microbiome across the life course

open access: yesFEBS Letters, EarlyView.
Despite significant individual variation and continuous change throughout life, the human gut microbiome follows some life stage‐specific trends. This article provides a brief overview of how gut microbiome composition shifts across different phases of life. Created in BioRender. Özkurt, E. (2026) https://BioRender.com/8q4nrnc.
Alise J. Ponsero   +4 more
wiley   +1 more source

Potential therapeutic targeting of BKCa channels in glioblastoma treatment

open access: yesMolecular Oncology, EarlyView.
This review summarizes current insights into the role of BKCa and mitoBKCa channels in glioblastoma biology, their potential classification as oncochannels, and the emerging pharmacological strategies targeting these channels, emphasizing the translational challenges in developing BKCa‐directed therapies for glioblastoma treatment.
Kamila Maliszewska‐Olejniczak   +4 more
wiley   +1 more source

Throughput Analysis of LAA and Wi-Fi Coexistence Network With Asynchronous Channel Access

open access: yesIEEE Access, 2018
The licensed-assisted access (LAA) technology has been proposed as a promising solution to increase the network capability by extending the frequency bands for long term evolution networks.
Zhenzhou Tang   +3 more
semanticscholar   +1 more source

Plecstatin inhibits hepatocellular carcinoma tumorigenesis and invasion through cytolinker plectin

open access: yesMolecular Oncology, EarlyView.
The ruthenium‐based metallodrug plecstatin exerts its anticancer effect in hepatocellular carcinoma (HCC) primarily through selective targeting of plectin. By disrupting plectin‐mediated cytoskeletal organization, plecstatin inhibits anchorage‐dependent growth, cell polarization, and tumor cell dissemination.
Zuzana Outla   +10 more
wiley   +1 more source

A novel channel access algorithm based on clusters and MAB model in cognitive vehicular network

open access: yesDianxin kexue, 2016
Considering the cognitive channel access problem of vehicle nodes in cognitive vehicular networks with heavy traffic environment,a channel access algorithm called clusters-UCB which based on clusters and MAB model was proposed.The cooperation of cluster ...
Fei PENG, Guoan ZHANG, Yuqi YANG
doaj  

Joint Source-Channel Coding over a Fading Multiple Access Channel with Partial Channel State Information

open access: yes, 2009
In this paper we address the problem of transmission of correlated sources over a fast fading multiple access channel (MAC) with partial channel state information available at both the encoders and the decoder.
Rajesh, R, Sharma, Vinod
core  

Phenotypic and genotypic characterization of single circulating tumor cells in the follow‐up of high‐grade serous ovarian cancer

open access: yesMolecular Oncology, EarlyView.
Single circulating tumor cells (sCTCs) from high‐grade serous ovarian cancer patients were enriched, imaged, and genomically profiled using WGA and NGS at different time points during treatment. sCTCs revealed enrichment of alterations in Chromosomes 2, 7, and 12 as well as persistent or emerging oncogenic CNAs, supporting sCTC identity.
Carolin Salmon   +9 more
wiley   +1 more source

Half-Duplex Relaying for the Multiuser Channel

open access: yes, 2014
This work focuses on studying the half-duplex (HD) relaying in the Multiple Access Relay Channel (MARC) and the Compound Multiple Access Channel with a Relay (cMACr).
Lei, Ming, Soleymani, Mohammad Reza
core   +1 more source

The PI3Kδ inhibitor roginolisib (IOA‐244) preserves T‐cell function and activity

open access: yesMolecular Oncology, EarlyView.
Identification of novel PI3K inhibitors with limited immune‐related adverse effects is highly sought after. We found that roginolisib and idelalisib inhibit chronic lymphocytic leukemia (CLL) cells and Treg suppressive functions to similar extents, but roginolisib affects cytotoxic T‐cell function and promotion of pro‐inflammatory T helper subsets to a
Elise Solli   +7 more
wiley   +1 more source

Home - About - Disclaimer - Privacy